Introduction
The prevalence of human immunodeficiency virus (HIV) in the Republic of South Africa (RSA) is one of the highest in the world, estimated at 21.5% (Mboup, Musonda, Mhalu, & Essex, 2006) . A national survey conducted in 2009 indicates that 61% of sexually active individuals in RSA have been previously tested for HIV (South African Government Information, 2009) . Although this represents an improvement from a previous estimate of 47% in 2006, 39% of the sexually active population remains untested (South African Government Information, 2009).
Insufficient HIV testing presents a multifaceted problem. Testing services, and knowledge of one's HIV serostatus, provide an entry point for prevention and treatment of HIV (Peltzer, Matseke, Mzolo, & Majaja, 2009 ). Factors positively related to HIV testing in RSA include older age, greater education, greater HIV knowledge, higher risk perception, and knowing someone with HIV (Boulle et al., 2008; Hutchinson & Mahlalela, 2006; MacPhail, Pettifor, Moyo, & Rees, 2009; Shisana et al., 2005) . These same factors have been identified in other countries as being associated with testing (Bond, Lauby, & Batson, 2005; Chen, Erbelding, Yeh, & Page, 2010; Goodman & Berecochea, 1994; Stein & Nyamathi, 2000; Weiser et al., 2006) , in addition to factors like drug use and treatment (Bond et al., 2005; Goodman & Berecochea, 1994; Stein & Nyamathi, 2000) , female sex (Goodman & Berecochea, 1994; Weiser et al., 2006) , increased HIV risk behaviors (Goodman & Berecochea, 1994; Solomon, Moore, Gleghorn, Astemborski, & Vlahov, 1996; Song et al., 2011) , and access to testing and health care (Bond et al., 2005; Weiser et al., 2006) . Furthermore, the decision to utilize HIV testing is complicated by fear (Pettifor, MacPhail, Suchindran, & Delaney-Moretlwe, 2010) , stigma (Kalichman & Simbayi, 2003; Peltzer, Nzewi, & Mohan, 2004 ), health care system characteristics (Asante, 2007; World Health Organization [WHO], 2000; WHO, 2008) , and access to treatment (Asante, 2007; WHO, 2008) .
Although HIV testing is an important issue for the entire population, certain sub-groups such as drug users are especially high-risk, and should be targeted for testing. Non-injection drug use has been identified as an independent risk factor for HIV (Parry et al., 2008) , and is thought to facilitate risky sexual practices via impaired cognition and increased sexual desire (Drumright & Colfax, 2009; Parry, Carney, Petersen, Dewing, & Needle, 2009; Parry & Pithey, 2006) . Furthermore, non-injection drug use has become increasingly popular in RSA (Parry et al., 2009) . Cannabis is the most commonly used illicit substance (Peltzer & Ramlagan, 2007) with current and lifetime use estimated at 2.1% (Shisana et al., 2005) and 11Á19% (Kalichman et al., 2006) , respectively. Lifetime cocaine use is estimated at 2Á3% (Kalichman et al., 2006) , and heroin, methamphetamine, and crack cocaine use are also on the rise (Parry et al., 2009; Parry & Pithey, 2006) . In 2005, 45% of individuals in treatment facilities reported methamphetamine (Plu¨ddemann et al., 2006) , 18% reported crack cocaine/powdered cocaine, and 12% reported heroin (Parry & Pithey, 2006) as their primary or secondary substances of abuse.
Despite community-based examinations of HIV testing (Kalichman & Simbayi, 2003; Parry et al., 2009) , and knowledge that non-injection drug users (NIDUs) are a high-risk group (Drumright & Colfax, 2009; Parry et al., 2008) , there has been little investigation into testing among NIDUs in RSA. One study has examined the uptake of testing among individuals with high-risk sexual or substance use behaviors in Pretoria, RSA (Luseno & Wechsberg, 2009) , although it was restricted to an all female sample and lacked multivariate analyses. As a result, we aim to identify factors associated with prior HIV testing among a sample of black South African NIDUs. Selection of factors related to testing in this study was guided in part by the informationmotivation-behavioral skills model of health behavior (Fisher & Fisher, 1992) , which purports that information (knowledge) and motivation (beliefs and attitudes) are important for influencing HIV testing decisions. Knowledge of such factors will enable identification of sub-populations of NIDUs in need of targeted interventions to promote HIV testing.
Methods

Data source
The NEURO-HIV Epidemiologic Study is an epidemiological examination of neuropsychological, social-behavioral risk factors for HIV, hepatitis A, B, and C infections with sites in the United States (US), RSA, and Russia. This manuscript utilizes data from the RSA site, which enrolled participants between 2002 and 2006 in the Pretoria area. The study was funded by the National Institute on Drug Abuse (NIDA) Southern Africa Initiative as a supplement to a parent study (RO1 DA014498). The study and consent forms were approved in the US by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board and in South Africa by the South African Medical Research Ethics Committee. Informed consent procedures and baseline assessments were conducted at Louis Pasteur Medical Center at the University of Pretoria.
Participants
Participants were recruited from drug treatment programs, bars, emergency rooms, health clinics, and street outreach. Eligibility criteria included age 18Á40 years, self-report of cocaine and/or heroin use within the past six months, and living in or around Pretoria. Informed consent was obtained prior to baseline assessments. Participants received financial remuneration (200 ZAR, approximately US $25) for a completed visit. A total of 410 participants were recruited. This analysis excludes a small number of individuals (n028) who did not identify their race/ ethnicity as ''black South African'' because of substantial socioeconomic differences between black and non-black individuals in RSA (May, 1998; Seekings & Nattrass, 2005) . In addition, the number of nonblack subjects was too small to allow for analysis of data by race/ethnicity. Thus, the present study is based on cross-sectional data from the baseline assessment for a sample of 382 black South African participants, all of whom reported only non-injection drug use.
Measures
Participants completed an interviewer-administered assessment for the purpose of ascertaining demographic characteristics, as well as an intervieweradministered HIV-risk behavior interview, adapted from tools developed during landmark studies of HIV risk behavior (e.g., Vlahov, Anthony, Celentano, Solomon, & Chowdhury, 1991) . The interview was pilot-tested in RSA prior to use in this study. The HIV-risk behavior interview included information on drug-related HIV risk behaviors (e.g., relapse, cessation, etc.), a range of drugs used (e.g., cannabis, heroin, other opiates, cocaine, etc.), route of administration, frequency and quantity used, and information on sexual practices (e.g., number of partners, condom use, etc.). Interviews were conducted in English. Based on discussions with health professionals in RSA, it was anticipated that all participants would be fluent in English.
Blood and urine samples were collected during the baseline assessment visit. Urinalysis assessed the presence of psychoactive substances using gas chromatography-mass spectrometry methods. Blood samples were tested for HIV and viral hepatitis A, B, and C. Urinalysis and HIV testing were conducted at a laboratory operated by a national pathology service. Participants were notified of their HIV status following testing. HIV-positive participants were referred to treatment clinics and provided with counseling to prevent the spread of HIV. HIVnegative participants were offered HIV prevention counseling.
Variables
Demographic variables
Based on the observed distribution, age was categorized into tertiles (age B21, 21Á24, ]25). Education was categorized as less than a high school education, some high school, and a high school diploma or greater.
Drug use, HIV/AIDS-related personal experiences and risk perception, sexual practices, and HIV testing variables Drug types assessed via urinalysis included cannabinoids, cocaine, and opiates. Participants were also asked whether they know someone with HIV/AIDS (yes or no), and how likely they thought they were to become infected with HIV (no chance, very unlikely, somewhat to very likely, and do not know). Number of lifetime partners was assessed as a categorical variable. Response choices included less than three lifetime partners, three to five partners, six to 10 partners, and greater than 10 partners. Ever buying or selling sex (prostitution) was assessed (yes or no). HIV testing prior to study entry (yes or no) was also assessed.
Statistical analyses
Descriptive statistics were used to describe the sample. Chi-square (x 2 ) tests were used to assess the statistical significance of relationships between HIV testing prior to study entry and sociodemographic, drug use, HIV/AIDS-related personal experience and HIV risk perception, and sexual practices variables at an alpha level of 0.05. Bivariate and multivariate logistic regressions were used to calculate odds ratios (ORs), adjusted odds ratios (AORs), and 95% confidence intervals (CI). Variable selection for the multivariate model was based on the literature (Chen et al., 2010; Fisher & Fisher, 1992 ) and x 2 p-values B0.05 in bivariate models. Variables selected for the adjusted model included: sex, age, education, use of cannabinoids, knowing someone with HIV/AIDS, HIV risk perception, number of lifetime partners, and buying or selling sex.
All 382 participants provided information on prior testing. For each covariate, missing data was less than 4%. A complete case analysis was performed. The percentage of missing data was small and, therefore was not expected to bias the results (Lipsitz, Parzen, & Ewell, 1998) . All analyses were performed using STATA statistical software version 10.0 (StataCorp, 2007) .
Results
Participant characteristics
Participant characteristics are shown in Table 1 . Half (51%) were female and one-third (31%) reported prior testing. One-third (33%) of participants were under the age of 21, 30% were between ages 21 and 24, and 37% were 25 or older. Nearly half of the respondents (47.1%) had completed some high school. Eighty-five percent tested positive via urinalysis for cannabinoids, 36% for cocaine, and 56% for opiates. Fifty-nine percent of individuals reported knowing someone with HIV/AIDS, although 51% of participants believed that there was ''no chance'' they would become infected with HIV. Sixty-seven percent had three or more lifetime sexual partners, and 39% had ever bought or sold sex.
Correlates of prior HIV testing Demographic factors
Results from the logistic regression models are shown in Table 2 . Female sex (OR 06.24, 95% CI, 3.74Á10.42), older age (OR 02.27, 95% CI, 1.27Á 4.03; OR02.18, 95% CI, 1.25Á3.79), and having a high school education or greater (OR 02.00, 95% CI, 1.11Á3.64) were significantly associated with prior HIV testing in the unadjusted model. Female sex (AOR 07.91, 95% CI, 4.04Á15.50) and older age (AOR02.05, 95% CI, 1.06Á3.95; AOR 02.30, 95% CI, 1.17Á4.53) remained significantly associated in the adjusted model.
Drug use
A positive urinalysis for cannabinoids was significantly associated with a decreased likelihood of prior HIV testing (OR 00.48, 95% CI, 0.27Á0.86) in the unadjusted model. Use of other drugs was not associated with testing in either the unadjusted or adjusted models.
HIV/AIDS-related personal experience and risk perception
In the unadjusted model, knowing someone with HIV/AIDS was associated with prior testing (OR 02.28, 95% CI, 1.42Á3.64), and continued to be significant in the adjusted model (AOR01.92, 95% CI, 1.12Á3.29). Uncertainty of one's risk for becoming infected with HIV was significantly negatively associated with prior HIV testing (AOR00.45, 95% CI, 0.23Á0.87) in the adjusted model.
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Sexual practice factors
Buying or selling sex was associated with past HIV testing in the unadjusted model (OR 02.01, 95% CI, 1.29Á3.13). Having three to five lifetime sexual partners was significantly associated with prior HIV testing in the unadjusted (OR 02.69, 95% CI, 1.53Á 4.75) and adjusted (AOR 02.23, 95% CI, 1.17Á4.23) models.
Discussion
Only 31% of our sample reported prior HIV testing. This contrasts with population-level estimates indicating that 61% (South African Government Informa-tion, 2009) of individuals in RSA have ever been tested, as well as with community-based estimates suggesting higher rates of testing (Luseno & Wechsberg, 2009; MacPhail et al., 2009; Pettifor et al., 2010) . This finding is troubling when considering the high estimates of HIV in RSA, and that NIDUs are a prevalent and high-risk group (Drumright & Colfax, 2009; Parry et al., 2008; Parry et al., 2009) .
Females were much more likely than males to report prior testing. One possible explanation is that HIV testing is often offered at antenatal clinics in RSA (AVERT.org, 2010; MacPhail et al., 2009) . Regardless, this is encouraging; females bear a disproportionate burden of the HIV epidemic in RSA (13.3% of females versus 8.2% of males in RSA are HIV '; Shisana et al., 2005) . Given these findings, the fact that HIV transmission in RSA is primarily driven by heterosexual intercourse (WHO, 2008) , and that male-to-female transmission of HIV occurs at a much higher rate than female-to-male transmission (MacPhail, Williams, & Campbell, 2002; Nicolosi et al., 1994) , males should be targeted for AIDS Care 1523 testing. It is possible that the epidemic is partly driven by males with unknown serostatus, who might otherwise modify behavior in favor of prevention. Consistent with previous work (Hutchinson & Mahlalela, 2006; Shisana et al., 2005) , older individuals were more likely to report prior testing. Younger individuals may be less likely to perceive a need for testing due to an optimistic bias regarding future health, or as a result of misinformation regarding HIV. Another finding, consistent with prior research (Hutchinson & Mahlalela, 2006; MacPhail et al., 2009) , shows that participants who know someone with HIV/AIDS were nearly twice as likely to report prior HIV testing. It is possible that people who do not personally know someone with HIV/AIDS may be lacking a salient example of how HIV/AIDS can affect someone's life.
Participants who were unsure of their risk for HIV infection were 55% less likely to report prior testing, as compared to those believing that there was ''no chance'' that they would become infected with HIV. Efforts to promote awareness of HIV risk and subsequent promotion of HIV testing among this group can possibly be achieved as part of existing HIV and sex education programs in South African schools (IRIN/PlusNews, 2008) . Due to high rates of school dropout in RSA, and since dropout is associated with early and unsafe sexual behavior (Odum & Drolet, 1997; World Bank, 2002) , these prevention efforts should be targeted toward younger children, while many are still enrolled in school and before most have become sexually active (Ahmed, Flisher, Mathews, Mukoma, & Jansen, 2009 ). Another novel finding is that having three to five lifetime sexual partners, as compared to fewer than three partners, was associated with a greater likelihood of reporting past testing. One possible explanation is that individuals with three to five lifetime sexual partners were significantly more likely to be female (p 00.037; data not shown), and therefore more likely to have been tested.
The decision to seek HIV testing can be complicated. Significant barriers must be dealt with when attempting to increase routine testing, including stigma, health care system characteristics, and access to treatment. In addition to being widespread, HIV/ AIDS is highly stigmatized in RSA. In a national survey, 26% of respondents indicated that they were unwilling to share a meal with, 18% were unwilling to sleep in the same room with, and 6% would not talk to someone with AIDS (Shisana & Simbayi, 2002) . These attitudes may reduce willingness to undergo testing, and also serve to socially isolate individuals with known HIV-positive status (Kalichman & Simbayi, 2003; Peltzer et al., 2004) .
Characteristics inherent to health care systems in Africa, and utilization of these services must be considered. For various reasons, health care systems in Africa have been considered weak, with an inadequate workforce to serve the population (WHO, 2000) . Africans, particularly the poor, tend not to use health care unless they are very ill. In the case of HIV/AIDS, waiting until an advanced stage of the disease manifests before seeking treatment has led to early death rates, which has further threatened the credibility of antiretroviral therapy (ART) delivery in RSA (Lawn et al., 2008) . Furthermore, research suggests that individuals with substance abuse problems in RSA have a reduced likelihood of accessing health care services (Luseno, Wechsberg, Kline, & Middlesteadt Ellerson, 2010) . ART uptake is also low among South Africans. At the end of 2007, only 28% of infected persons were receiving treatment for HIV; this rate is below average as compared to other lowerand middle-income countries (WHO, 2008) .
Another issue is access to treatment following testing. Access to treatment and medical care is essential to encouraging individuals to utilize testing (Asante, 2007) . In fact, research shows that individuals in RSA would be more willing to get tested for HIV if ART was easily available following testing (Pettifor et al., 2010) . Although knowledge of one's serostatus, even without treatment, could induce behavior change that may reduce HIV transmission, undergoing testing when there is no access to treatment may seem futile to many (Asante, 2007) . RSA has the largest ART program in the world, but given that it also has one of the world's largest HIV epidemics, access to treatment is low (http:// AVERT.org).
Limitations of the study should be acknowledged. First, this study is cross-sectional. Therefore, conclusions cannot be drawn regarding the temporal order of variables examined. This was a non-random sample, focused on a hard-to-reach population. In addition, all participants self-reported their race to be black African. Due to the substantial socioeconomic differences between races in RSA (Seekings & Nattrass, 2005) , and the fact that poverty is largely concentrated among blacks (61% of black Africans are poor, compared with 1% of whites; May, 1998) , these findings may not generalize to NIDUs of other races. Furthermore, it should be noted that the outcome variable Á lifetime HIV testing Á is not an optimal measure. A more in-depth assessment of HIV testing should include frequency of testing, how recently testing was accessed, and so on.
Given these limitations, future studies could collect information not available in the present study: access to testing, perceptions of stigma that act as barriers to testing and treatment, awareness of and access to treatment, as well as examine the associations between testing and other key HIV risk determinants among substance users, such as gender differences, sexually transmitted infections, experiences with violence, incarceration, and so on. In addition, the present sample was largely recruited from treatment and health care facilities. Since many of the participants were already accessing health care, and only 31% of these individuals were previously tested, these facilities represent important locations for routine testing to be promoted and offered.
Despite the identified limitations, this study fills an important gap in the literature by examining factors associated with prior HIV testing among black South African NIDUs, a relatively understudied hard-to-reach population. The findings have identified several subgroups of NIDUs for whom targeted promotion of HIV testing could be beneficial. Knowledge of one's HIV serostatus can play an important role in curtailing the spread of HIV by allowing individuals to engage in prevention strategies, and by providing an entry point to HIV treatment. Such knowledge is especially important among high-risk groups and in areas of the world where HIV is endemic.
